ONO-8713

CAS No. 459411-08-6

ONO-8713( —— )

Catalog No. M35732 CAS No. 459411-08-6

ONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist used to study diseases of the biblical system and metabolism-related diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1121 In Stock
25MG 1501 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ONO-8713
  • Note
    Research use only, not for human use.
  • Brief Description
    ONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist used to study diseases of the biblical system and metabolism-related diseases.
  • Description
    ONO-8713 is a selective prostaglandin E receptor subtype EP1 antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    459411-08-6
  • Formula Weight
    523.52
  • Molecular Formula
    C25H24F3NO6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(S(=O)(=O)C1=CC=CO1)(CC(C)C)C2=C(OCC3=CC=C(C=CC(O)=O)C=C3)C=C(C(F)(F)F)C=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Watanabe K, et al. Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Lett. 2000 Aug 1;156(1):57-61. ?
molnova catalog
related products
  • BGC201531

    BGC201531 is a EP4 antagonist for the treatment of acute migraine.

  • Bimatoprost

    Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.

  • OBE022

    OBE022 is a potent, highly selective, orally active antagonist of the contractile PGF2α prostaglandin receptor with Kb of 5.9 nM.